Back to top
more

Johnson & Johnson (JNJ)

(Real Time Quote from BATS)

$160.32 USD

160.32
900,685

+0.63 (0.40%)

Updated Oct 9, 2024 11:20 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (33 out of 252)

Industry: Large Cap Pharmaceuticals

Better trading starts here.

Zacks News

Johnson & Johnson (JNJ) Q4 Earnings Top Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.86% and 0.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Is WisdomTree U.S. Quality Dividend Growth ETF (DGRW) a Strong ETF Right Now?

Smart Beta ETF report for DGRW

Mark Vickery headshot

Markets Stay Positive on Perceived Fed Slowing

We're either letting the stern part of the narrative get past us or we're breathing some life into oversold indices. Perhaps a little of both.

Lilly (LLY) Jardiance Kidney Disease sNDA Gets FDA Acceptance

Eli Lilly's (LLY) sNDA seeks approval for diabetes medicine, Jardiance, to reduce the risk of kidney disease progression and cardiovascular death in adults with CKD.

Andrew Rocco headshot

Market on Tipping Point of New Bull Trend: These 5 Charts Illustrate Why

You never really know when a new bull trend has arrived for sure. However, by looking at different sides of the market you can begin to put the pieces of the puzzle together.

Discover Financial, Kimberly Clark, Johnson & Johnson and Synchrony Financial are part of Zacks Earnings Preview

Discover Financial, Kimberly Clark, Johnson & Johnson and Synchrony Financial are highlights of Zacks Earnings Preview article.

Sheraz Mian headshot

Making Sense of the Early Q4 Results: Is An Earnings Cliff Coming?

By the end of this week, we will have seen quarterly results from about 28% of all S&P 500 members and will have a very good sense of whether the earnings-cliff narrative has started unfolding or been further pushed out.

Kinjel Shah headshot

Pharma Stock Roundup: LLY's Donanemab Gets FDA's CRL, MRNA RSV Jab Study Succeeds

FDA gives CRL to Lilly's (LLY) Alzheimer's candidate, donanemab. Moderna's (MRNA) phase III study on its mRNA-based RSV vaccine candidate in older adults meets primary efficacy endpoints

J&J (JNJ) to Begin Q4 Earnings Season for Pharma Sector

Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.

Is Vanguard High Dividend Yield ETF (VYM) a Strong ETF Right Now?

Smart Beta ETF report for VYM

J&J (JNJ) Discontinues HIV Vaccine Phase III Mosaico Study

J&J (JNJ) discontinues phase III study on its investigational HIV vaccine regimen, which shows that the candidate lacks efficacy in preventing HIV.

Should Vanguard Russell 1000 Value ETF (VONV) Be on Your Investing Radar?

Style Box ETF report for VONV

Johnson & Johnson (JNJ) Stock Moves -1.51%: What You Should Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $169.76, marking a -1.51% move from the previous day.

Should Vanguard S&P 500 Value ETF (VOOV) Be on Your Investing Radar?

Style Box ETF report for VOOV

Is iShares Core Dividend Growth ETF (DGRO) a Strong ETF Right Now?

Smart Beta ETF report for DGRO

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Halozyme (HALO) Down 9.2% on Weak 2023 Financial Guidance

Though Halozyme (HALO) expects a year-over-year increase in revenues and earnings for 2023, the company's guidance fell short of Wall Street expectations.

Tracey Ryniec headshot

How to Use Zacks Earnings Surprise Charts

If you're trading on the earnings report, you will want to check out these charts.

Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

Sector ETF report for IYH

Should Vanguard Mega Cap Value ETF (MGV) Be on Your Investing Radar?

Style Box ETF report for MGV

Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $175.16, marking a -0.24% move from the previous day.

Emergent (EBS) to Start Restructuring Plan, Lays Off 5% Workforce

Once this restructuring activity is completed, Emergent BioSolutions (EBS) expects to result in annualized savings of over $60 million. It also slightly raised its total revenue guidance for 2022.

Should Invesco S&P 500 Low Volatility ETF (SPLV) Be on Your Investing Radar?

Style Box ETF report for SPLV